Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check5 days agoChange DetectedA new addition was made on December 24, 2024, while a deletion occurred on November 18, 2024.SummaryDifference0.6%
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check27 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check41 days agoChange DetectedOn November 18, 2024, new content was added, while a significant section detailing data download options and study information was removed on October 22, 2024.SummaryDifference14%
- Check48 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
- Check56 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and enhancing the data download options, while the previous version 2.12.1 has been removed.SummaryDifference17%
Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.